# Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

Study · id `cardio:ct-nct05780359` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05780359](<https://clinicaltrials.gov/study/NCT05780359>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05780359

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.

## Technical summary

Registry record NCT05780359. Randomized; single masking; primary purpose treatment. Start 2022-05-27 (actual); primary completion 2025-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 280 participants (planned count; ClinicalTrials.gov record NCT05780359, source copy `cardio:ctgov-nct05780359-2023-03-22`, retrieved 2026-10-31)
- Started: 2022-05-27 (actual) (ClinicalTrials.gov record NCT05780359, source copy `cardio:ctgov-nct05780359-2023-03-22`, retrieved 2026-10-31)
- Primary completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT05780359, source copy `cardio:ctgov-nct05780359-2023-03-22`, retrieved 2026-10-31)
- Completion: 2026-08-31 (anticipated) (ClinicalTrials.gov record NCT05780359, source copy `cardio:ctgov-nct05780359-2023-03-22`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT05780359, source copy `cardio:ctgov-nct05780359-2023-03-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05780359-2023-03-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
- Acronym: G-streamPAD
- Condition: Peripheral Artery Disease
- Intervention (Device): Drug eluting stent
- Intervention (Device): drug coating balloon
- Lead sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Changhai Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. (`cardio:org-shenzhen-salubris-pharmaceuticals-co-ltd`)
- Registry lists this organization as a collaborator: Changhai Hospital (`cardio:org-changhai-hospital`)

## Provenance

Content hash: 921672fac4abb6212d05a62374200633d645e6148183494e9554ca4cc83be2e7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
